Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials)

American Journal of Cardiology

Volumn 106, Issue 10, 2010, Pages 1436-1442

  Garg, Pallav ^a,b   Charytan, David M ^a,b   Novack, Lena ^b   Cutlip, Donald E ^b,c   Popma, Jeffrey J ^c   Moses, Jeffrey ^d   Leon, Martin B ^d   Schofer, Joachim ^e   Breithardt, Guenter ^f   Schampaert, Erick ^g   Mauri, Laura ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e UNIVERSITY HEART CENTER HAMBURG   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; RAPAMYCIN;

ADULT; ADVERSE OUTCOME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; KIDNEY FAILURE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; STABLE ANGINA PECTORIS; STENT THROMBOSIS; THERAPY EFFECT; UNSTABLE ANGINA PECTORIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY RESTENOSIS; DOUBLE-BLIND METHOD; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; SIROLIMUS; STENTS;

EID: 78149439662     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.07.011     Document Type: Article

References (18)

1. H. Kramer, W. Palmas, B. Kestenbaum, M. Cushman, M. Allison, B. Astor, and M. Shlipak Chronic kidney disease prevalence estimates among racial/ethnic groups: the Multi-Ethnic Study of Atherosclerosis Clin J Am Soc Nephrol 3 2008 1391 1397
2. F. Cardarelli, A. Bellasi, E. Veledar, V. Vaccarino, and P. Raggi Impact of race and chronic kidney disease on 1-year outcome in patients undergoing percutaneous coronary interventions: a single tertiary center experience Am Heart J 155 2008 1027 1032
3. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, C. O'Shaughnessy, R.P. Caputo, D.J. Kereiakes, D.O. Williams, P.S. Teirstein, J.L. Jaeger, and R.E. Kuntz Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
4. E. Schampaert, E.A. Cohen, M. Schluter, F. Reeves, M. Traboulsi, L.M. Title, R.E. Kuntz, and J.J. Popma The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (CSIRIUS) J Am Coll Cardiol 43 2004 1110 1115
5. J. Schofer, M. Schluter, A.H. Gershlick, W. Wijns, E. Garcia, E. Schampaert, and G. Breithardt Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099
6. D.W. Cockroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
7. A.S. Levey, J. Coresh, E. Balk, A.T. Kausz, A. Levin, M.W. Steffes, R.J. Hogg, R.D. Perrone, J. Lau, and G. Eknoyan National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Ann Intern Med 139 2003 137 147
8. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
9. R. Gupta, Y. Birnbaum, and B.F. Uretsky The renal patient with coronary artery disease: current concepts and dilemmas J Am Coll Cardiol 44 2004 1343 1353
10. F.G. Hage, R. Venkataraman, G.J. Zoghbi, G.J. Perry, A.M. DeMattos, and A.E. Iskandrian The scope of coronary heart disease in patients with chronic kidney disease J Am Coll Cardiol 53 2009 2129 2140
11. M.D. Osten, J. Ivanov, J. Eichhofer, P.H. Seidelin, J.R. Ross, A. Barolet, E.M. Horlick, D. Ing, L. Schwartz, K. Mackie, and V. Dzavik Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention Am J Cardiol 101 2008 780 785
12. P.J. Best, R. Lennon, H.H. Ting, M.R. Bell, C.S. Rihal, D.R. Holmes, and P.B. Berger The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions J Am Coll Cardiol 39 2002 1113 1119
13. A. Halkin, R. Mehran, C.W. Casey, P. Gordon, R. Matthews, B.H. Wilson, M.B. Leon, M.E. Russell, S.G. Ellis, and G.W. Stone Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial Am Heart J 150 2005 1163 1170
14. M.H. Rubenstein, L.C. Harrell, B.V. Sheynberg, H. Schunkert, H. Bazari, and I.F. Palacios Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 102 2000 2966 2972
15. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
16. E.L. Schiffrin, M.L. Lipman, and J.F. Mann Chronic kidney disease: effects on the cardiovascular system Circulation 116 2007 85 97
17. I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G.M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, N. Corvaja, C. Briguori, U. Gerckens, E. Grube, and A. Colombo Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
18. F. Latif, N.S. Kleiman, D.J. Cohen, M.J. Pencina, C.H. Yen, D.E. Cutlip, D.J. Moliterno, D. Nassif, J.J. Lopez, and J.F. Saucedo In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry JACC Cardiovasc Interv 2 2009 37 45